[Effects of cis-platinum diammine dichloride on yolk sac tumor transplanted in nude mice (author's transl)]. 1981

M Sawada, and Y Matsui, and H Nishiura, and M Yagyu, and K Hayakawa, and Y Okudaira, and M Kawashima, and K Iwanaga

Effects of new anticancer drug Cis-platinum dichloride (CPDD) on yolk sac tumor were studied. Human yolk sac tumor serially transplanted in BALB/c nude mice (YST-1) was used as material in this experiment. Two administration methods of CPDD were examined and compared. 1) CPDD 5 mg/kg X 1 day X 4 2) CPDD i mg/kg X 5 days X 4. Tumor size was measured and serum AFP of nude mice was determined by radioimmunoassay method during experiments. At the end of experiments, treated tumor was resected and examined by light and electron microscopy. Results as follows: 1. CPDD was active in regressing yolk sac tumor at doses of 5 mg/kg given as a single treatment and doses of 1 mg/kg given daily for five days. It appeared that CPDD showed higher activity against tumors by daily injections at doses of 1 mg/kg. 2. Close correlation was recognized between tumor size and serum AFP of nude mice ((r = 0.93, p less than 0.001). Serum AFP of tumor-bearing nude mice revealed to be a useful marker of yolk sac tumor also in nude mice as in human patient. 3. Effect of CPDD on tumor cells was confirmed by light and electron microscopy.

UI MeSH Term Description Entries
D008649 Mesonephroma A rare tumor of the female genital tract, most often the ovary, formerly considered to be derived from mesonephric rests. Two varieties are recognized: (1) clear cell carcinoma, so called because of its histologic resemblance to renal cell carcinoma, and now considered to be of muellerian duct derivation and (2) an embryonal tumor (called also ENDODERMAL SINUS TUMOR and yolk sac tumor), occurring chiefly in children. The latter variety may also arise in the testis. (Dorland, 27th ed) Mesonephromas
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

M Sawada, and Y Matsui, and H Nishiura, and M Yagyu, and K Hayakawa, and Y Okudaira, and M Kawashima, and K Iwanaga
January 1978, Chirurgie pediatrique,
M Sawada, and Y Matsui, and H Nishiura, and M Yagyu, and K Hayakawa, and Y Okudaira, and M Kawashima, and K Iwanaga
December 1977, Gan,
M Sawada, and Y Matsui, and H Nishiura, and M Yagyu, and K Hayakawa, and Y Okudaira, and M Kawashima, and K Iwanaga
December 1980, Cancer,
M Sawada, and Y Matsui, and H Nishiura, and M Yagyu, and K Hayakawa, and Y Okudaira, and M Kawashima, and K Iwanaga
January 1991, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
M Sawada, and Y Matsui, and H Nishiura, and M Yagyu, and K Hayakawa, and Y Okudaira, and M Kawashima, and K Iwanaga
November 1983, Mutation research,
M Sawada, and Y Matsui, and H Nishiura, and M Yagyu, and K Hayakawa, and Y Okudaira, and M Kawashima, and K Iwanaga
April 1977, Cancer,
M Sawada, and Y Matsui, and H Nishiura, and M Yagyu, and K Hayakawa, and Y Okudaira, and M Kawashima, and K Iwanaga
January 2004, Anticancer research,
M Sawada, and Y Matsui, and H Nishiura, and M Yagyu, and K Hayakawa, and Y Okudaira, and M Kawashima, and K Iwanaga
May 1982, Nihon Sanka Fujinka Gakkai zasshi,
M Sawada, and Y Matsui, and H Nishiura, and M Yagyu, and K Hayakawa, and Y Okudaira, and M Kawashima, and K Iwanaga
October 1983, Gan no rinsho. Japan journal of cancer clinics,
M Sawada, and Y Matsui, and H Nishiura, and M Yagyu, and K Hayakawa, and Y Okudaira, and M Kawashima, and K Iwanaga
October 1981, Nihon Sanka Fujinka Gakkai zasshi,
Copied contents to your clipboard!